Jubilant Pharmova Ltd: Stock Analysis & Fundamentals

Updated this week

Jubilant Pharmova Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 29.1. ROE: 9.6%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

👔Promoter stake down 3.0% this quarter

🌐FII stake decreased 1.4% this quarter

🏛️DII accumulation — stake up 4.9%

Key Numbers

Current Price

₹844

Dividend Yield

0.59%

Market Cap

13.4K Cr

Valuation

N/A

Other Top Pharma - API & CRAMS Stocks Beating Nifty 500

Gland Pharma Ltd

Average

+15.9%

Acutaas Chemicals Ltd

SMS Pharmaceuticals Ltd

Average • 12w streak

+37.7%

← Back to Pharma - API & CRAMS Dashboard

Frequently Asked Questions: Jubilant Pharmova Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Jubilant Pharmova Ltd's latest quarterly results?

Jubilant Pharmova Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: -44.6%
Revenue Growth YoY: +16.5%
Operating Margin: 14.0%

What is Jubilant Pharmova Ltd's current PE ratio?

Jubilant Pharmova Ltd's current PE ratio is 29.1x.

Current PE: 29.1x
Market Cap: 13.4K Cr
Dividend Yield: 0.59%

What is Jubilant Pharmova Ltd's price-to-book ratio?

Jubilant Pharmova Ltd's price-to-book ratio is 2.0x.

Price-to-Book (P/B): 2.0x
Book Value per Share: ₹414
Current Price: ₹844

Is Jubilant Pharmova Ltd a fundamentally strong company?

Jubilant Pharmova Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 10.0%

Is Jubilant Pharmova Ltd debt free?

Jubilant Pharmova Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹3,000 Cr

What is Jubilant Pharmova Ltd's return on equity (ROE) and ROCE?

Jubilant Pharmova Ltd's return ratios over recent years

FY2023: ROCE 3.0%
FY2024: ROCE 7.0%
FY2025: ROCE 10.0%

Is Jubilant Pharmova Ltd's cash flow positive?

Jubilant Pharmova Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹1,000 Cr
Free Cash Flow (FCF): ₹2,000 Cr
CFO/PAT Ratio: 128% (strong cash conversion)

What is Jubilant Pharmova Ltd's dividend yield?

Jubilant Pharmova Ltd's current dividend yield is 0.59%.

Dividend Yield: 0.59%
Current Price: ₹844

Who holds Jubilant Pharmova Ltd shares — promoters, FII, DII?

Jubilant Pharmova Ltd's shareholding pattern (Dec 2025)

Promoters: 47.7%
FII (Foreign): 16.0%
DII (Domestic): 11.2%
Public: 24.6%

Is promoter holding increasing or decreasing in Jubilant Pharmova Ltd?

Jubilant Pharmova Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 47.7% (Dec 2025)
Previous Quarter: 47.7% (Sep 2025)
Change: 0.00% (stable)

Is Jubilant Pharmova Ltd a new momentum entry or an established outperformer?

Jubilant Pharmova Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Jubilant Pharmova Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Jubilant Pharmova Ltd may be worth studying

Cash flow is positive — CFO ₹1,000 Cr

What is the investment thesis for Jubilant Pharmova Ltd?

Jubilant Pharmova Ltd investment thesis summary:

What is the future outlook for Jubilant Pharmova Ltd?

Jubilant Pharmova Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.